Stay updated on BI 695500 Clinical Trial in RA: Efficacy, PK, Safety
Sign up to get notified when there's something new on the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page.

Latest updates to the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page
- Check5 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check12 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies site revision v3.7.1 instead of v3.7.0; the page remains a 403 error screen.SummaryDifference0.2%

- Check19 days agoChange DetectedThe study page displays a 403 Forbidden message instead of study information, so the clinical trial record cannot be viewed.SummaryDifference0.5%

- Check33 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record, and the view appears to present a minimal header/footer with the error message, making the previously available study details inaccessible in this view.SummaryDifference18%

- Check54 days agoChange DetectedA new page revision tag, Revision: v3.6.6, appears replacing Revision: v3.6.5, indicating an update to the page's revision history.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded a Synopsis Link and sponsor attribution (Boehringer Ingelheim) to the Study Details page, along with a 'Helpful Links Provided by' label and a note about drug and device information, study documents, and other helpful links. These changes provide direct access to official materials and clarify the study's sponsor.SummaryDifference0.1%

Stay in the know with updates to BI 695500 Clinical Trial in RA: Efficacy, PK, Safety
Enter your email address, and we'll notify you when there's something new on the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page.